Skip to main content

Ipamorelin CJC-1295 Protocol

Meaning

A specific therapeutic regimen involving the combined administration of two synthetic peptides: Ipamorelin, a selective growth hormone secretagogue, and CJC-1295, a growth hormone-releasing hormone (GHRH) analog. This protocol is designed to synergistically stimulate the pulsatile, physiological release of endogenous Growth Hormone (GH) from the pituitary gland. It is a strategy employed in anti-aging and performance medicine to optimize body composition, cellular repair, and overall vitality without introducing exogenous GH.